Li Hui, Zhong Qun Feng, Liu Qiong Rong, Wu Qiang, Zhang Wen, Luo Guo Pei
Department of General Surgery, Xingguo Hospital Affiliated to Gannan Medical College, Jiangxi 342400, China.
Department of Ultrasound Medicine, Xingguo Hospital Affiliated to Gannan Medical College, Jiangxi 342400, China.
Gastroenterology Res. 2024 Jun;17(3):126-132. doi: 10.14740/gr1710. Epub 2024 Jun 29.
With the advancement of laparoscopic technology, the combination of laparoscopy, choledochoscopy, and holmium laser lithotripsy has emerged as an effective treatment modality for both choledocholithiasis and hepatolithiasis. This study aimed to assess the efficacy and safety of this approach.
Retrospective analysis was conducted on the medical records of 76 patients diagnosed with choledocholithiasis and hepatolithiasis between April 2021 and March 2023. Patients were divided into two groups based on the treatment plan: the control group, which underwent traditional laparotomy and choledochoscopy lithotripsy (n = 38), and the experimental group, which underwent laparoscopy combined with choledochoscopy and holmium laser lithotripsy (n = 38). Comparative analysis was performed on various operation-related parameters, stone-free rate, complication rates, and changes in biochemical, liver function, inflammatory, stress response indicators, and pain scores between the two groups.
The experimental group demonstrated significantly shorter stone removal time, reduced intraoperative bleeding, and shorter hospital stay compared to the control group (P < 0.05). Moreover, the experimental group exhibited lower incidence of postoperative complications and lower pain scores at 2 weeks to 3 months post-operation (P < 0.05). Biochemical indicators including total bile acid (TBA), total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and glutamyl transpeptidase (GGT) were significantly lower in the observation group compared to the control group (P < 0.05). Additionally, stress and inflammation indicators were also lower in the experimental group (P < 0.05).
The combination of laparoscopy, choledochoscopy, and holmium laser lithotripsy presents favorable therapeutic outcomes in the management of choledocholithiasis and hepatolithiasis, indicating its potential for widespread clinical application.
随着腹腔镜技术的进步,腹腔镜、胆道镜和钬激光碎石术的联合应用已成为治疗胆总管结石和肝内胆管结石的一种有效治疗方式。本研究旨在评估该方法的有效性和安全性。
对2021年4月至2023年3月期间诊断为胆总管结石和肝内胆管结石的76例患者的病历进行回顾性分析。根据治疗方案将患者分为两组:对照组,接受传统剖腹手术和胆道镜碎石术(n = 38);实验组,接受腹腔镜联合胆道镜和钬激光碎石术(n = 38)。对两组患者的各项手术相关参数、结石清除率、并发症发生率以及生化、肝功能、炎症、应激反应指标和疼痛评分的变化进行比较分析。
与对照组相比,实验组的结石清除时间明显缩短,术中出血减少,住院时间缩短(P < 0.05)。此外,实验组术后并发症发生率较低,术后2周~3个月的疼痛评分也较低(P < 0.05)。观察组的总胆汁酸(TBA)、总胆红素(TBIL)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(ALP)和谷氨酰转肽酶(GGT)等生化指标明显低于对照组(P < 0.05)。此外,实验组的应激和炎症指标也较低(P < 0.05)。
腹腔镜、胆道镜和钬激光碎石术联合应用在胆总管结石和肝内胆管结石的治疗中具有良好的治疗效果,表明其具有广泛临床应用的潜力。